These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 9154322)
21. Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater. Buzzi MG; Moskowitz MA; Peroutka SJ; Byun B Br J Pharmacol; 1991 Jun; 103(2):1421-8. PubMed ID: 1653072 [TBL] [Abstract][Full Text] [Related]
22. Recombinant saphenous vein 5-HT1B receptors of the rabbit: comparative pharmacology with human 5-HT1B receptors. Wurch T; Palmier C; Colpaert FC; Pauwels PJ Br J Pharmacol; 1997 Jan; 120(1):153-9. PubMed ID: 9117091 [TBL] [Abstract][Full Text] [Related]
23. Magnitude of 5-HT1B and 5-HT1A receptor activation in guinea-pig and rat brain: evidence from sumatriptan dimer-mediated [35S]GTPgammaS binding responses. Dupuis DS; Perez M; Halazy S; Colpaert FC; Pauwels PJ Brain Res Mol Brain Res; 1999 Apr; 67(1):107-23. PubMed ID: 10101238 [TBL] [Abstract][Full Text] [Related]
24. 5-HT1D receptor agonists and human coronary artery reactivity in vitro: crossover comparisons of 5-HT and sumatriptan with rizatriptan and L-741,519. Longmore J; Boulanger CM; Desta B; Hill RG; Schofield WN; Taylor AA Br J Clin Pharmacol; 1996 Oct; 42(4):431-41. PubMed ID: 8904614 [TBL] [Abstract][Full Text] [Related]
28. How efficacious are 5-HT1B/D receptor ligands: an answer from GTP gamma S binding studies with stably transfected C6-glial cell lines. Pauwels PJ; Tardif S; Palmier C; Wurch T; Colpaert FC Neuropharmacology; 1997; 36(4-5):499-512. PubMed ID: 9225275 [TBL] [Abstract][Full Text] [Related]
29. The effects of 5-HT1A, 5-HT1B and 5-HT1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats. Cumberbatch MJ; Hill RG; Hargreaves RJ Eur J Pharmacol; 1998 Nov; 362(1):43-6. PubMed ID: 9865528 [TBL] [Abstract][Full Text] [Related]
30. Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation. Razzaque Z; Heald MA; Pickard JD; Maskell L; Beer MS; Hill RG; Longmore J Br J Clin Pharmacol; 1999 Jan; 47(1):75-82. PubMed ID: 10073743 [TBL] [Abstract][Full Text] [Related]
31. Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat. Hoskin KL; Goadsby PJ Exp Neurol; 1998 Mar; 150(1):45-51. PubMed ID: 9514827 [TBL] [Abstract][Full Text] [Related]
32. Bovine isolated middle cerebral artery contractions to antimigraine drugs. Roon KI; Maassen Van Den Brink A; Ferrari MD; Saxena PR Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):591-6. PubMed ID: 10598799 [TBL] [Abstract][Full Text] [Related]
33. The 5-HT1D receptor antagonist GR-127,935 prevents inhibitory effects of sumatriptan but not CP-122,288 and 5-CT on neurogenic plasma extravasation within guinea pig dura mater. Yu XJ; Cutrer FM; Moskowitz MA; Waeber C Neuropharmacology; 1997 Jan; 36(1):83-91. PubMed ID: 9144644 [TBL] [Abstract][Full Text] [Related]
34. Pharmacological characterization of almotriptan: an indolic 5-HT receptor agonist for the treatment of migraine. Bou J; Domènech T; Puig J; Heredia A; Gras J; Fernández-Forner D; Beleta J; Palacios JM Eur J Pharmacol; 2000 Dec; 410(1):33-41. PubMed ID: 11134654 [TBL] [Abstract][Full Text] [Related]
35. Zolmitriptan stimulates a Ca(2+)-dependent K(+) current in C6 glioma cells stably expressing recombinant human 5-HT(1B) receptors. Le Grand B; Panissié A; Perez M; Pauwels PJ; John GW Eur J Pharmacol; 2000 Jun; 397(2-3):297-302. PubMed ID: 10844127 [TBL] [Abstract][Full Text] [Related]
36. Characterisation of the contractile activity of eletriptan at the canine vascular 5-HT1B receptor. Gupta P; Scatchard J; Napier C; McHarg A; Wallis R Eur J Pharmacol; 1999 Feb; 367(2-3):283-90. PubMed ID: 10079003 [TBL] [Abstract][Full Text] [Related]